Editorial: Obesity management with next-generation drugs
Obesity and the associated morbidity and mortality have long been a significant chronic disease challenge for healthcare systems worldwide. Current treatment options use lifestyle modifications, medication, or bariatric surgery to induce a negative energy balance. While medications for obesity have been available for decades, healthcare providers have often been hesitant to prescribe them due to concerns about potential side effects and the necessity of long-term use. However, it is important to recognize that side effects of medications are a common possibility, and yet medications are prescribed when their benefits outweigh the potential risks. Not treating obesity effectively also poses its own risk, which needs to be recognized when considering obesity medications. Similarly, a chronic disease such as obesity needs chronic treatment, including medications, if indicated, much the same as lifelong treatment for diabetes, another chronic disease.
History
School
- Sport, Exercise and Health Sciences
Published in
International Journal of ObesityVolume
49Issue
3Pages
367 - 368Publisher
Springer Science and Business Media LLCVersion
- AM (Accepted Manuscript)
Rights holder
©The Author(s), under exclusive licence to Springer Nature Limited 2025Publisher statement
This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1038/s41366-025-01734-4Acceptance date
2025-02-13Publication date
2025-02-27Copyright date
2025ISSN
0307-0565eISSN
1476-5497Publisher version
Language
- en